Northwest Urological Society 2008 Agenda

Fri Dec 5, 2008

Health Policy Agenda

8:00 Opening Remarks Tom Hatch, MD

NWUS President
8:05 Getting Positive Results From your Contract Negotiations
Naya Keyhayes MPH
8:30 Employment Law Update for your Practice
Jack Cooper JD
9:00 Panel Discussion moderated by Tom Hatch, MD

9:15 BREAK

9:30 Residency Training Programs and the Future of Urology Recruitment

John Barry MD AUA President

10:00 Legislative Issues Critical to Urology Jeff Kaufman MD

AUA Health Policy Chair
AACU Past President
10:30 Panel Discussion moderator by Mark Uhlman, MD
John Barry, MD (AUA President)
Jeff Frankel, MD (AACU President-Elect)
Jeff Kaufman, MD (AUA Health Policy Chair)

11:05 The Future of Medicine in America Dr. John Kitzhaber

Former Oregon State Governor
11:45 Q & A

12:00 Lunch

Scientific Session Agenda

1:00 Opening Remarks Sia Daneshmand, MD

NWUS Program Chair
1:05 Keynote Lecture:
Current role of BCG in the Management of Non-invasive Bladder Cancer
Donald Lamm, M.D.
Vice Chair for Research – Urologic Oncology
Department of Urology, Mayo Clinic, Scottsdale, Arizona
1:45 Scientific Session I:
Oncology I

Podium 1-1 DOES THE ABILITY TO PERFORM RALP EXPAND THE POPULATION OF PATIENTS
UNDERGOING SURGERY FOR THE MANAGEMENT OF PROSTATE CANCER?- Abtract # 837
Anthony J Woodruff MD, Erin M Odom MD and John M Corman MD, Seattle, WA
Podium 1-2 PT0 IS NOT BENIGN DISEASE: THERE IS A RISK OF PROGRESSION IN PATIENTS WITH NO
CANCER IN RADICAL PROSTATECTOMY SPECIMENS- Abstract # 804
Jennifer L. Gurski, Andrew C. Peterson MD, Timothy C. Brand MD. Madigan Army Medical Center, Tacoma, WA.

Podium 1-3 THE COMBINATION OF ANTISENSE OLIGONUCLEOTIDES TARGETING HEAT-SHOCK

PROTEIN-27 WITH HTI-286 AS A NOVEL INTRAVESICAL TREATMENT FOR HIGH-GRADE BLADDER
CANCER- Abstract # 831
Yoshiyuki Matsui, Boris A. Hadaschik MD, Martin E. Gleave MD and Alan I.SoMD
The Prostate Centre at Vancouver General Hospital, Vancouver, BC, Canada

Podium 1-4 PERIOPERATIVE MORTALITY FROM RADICAL CYSTECTOMY - A MODERN SERIES- Abstract
#835
Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR

Podium 1-5 FACTORS INFLUENCING CHOICE OF URINARY DIVERSION FOLLOWING RADICAL

CYSTECTOMY- Abstract #826
Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR

Podium 1-6 AORTIC REPLACEMENT DURING POST-CHEMO RETROPERITONEAL LYMPH NODE

DISSECTION- Abstract #841
Sia Daneshmand, MD Section of Urologic Oncology, Division of Urology & Renal Transplantation
Oregon Health & Science University, Portland, OR

2:30 Break/ View Exhibits

3:00 Scientific Session II:

Endourology/ Minimally Invasive Surgery

Podium 2-1 IN-OFFICE LASER VAPORIZATION OF THE PROSTATE- Abstract #809

Gregory B. McCoy, M.D., The Urology Clinic, Portland, Oregon

Podium 2-2 USE OF ANTEGRADE SALLE STENT IN LAPAROSCOPIC PYELOPLASTY- Abstract #810
Brian C. Fong, MD: Western Washington Medical Group, Department of Urology, Everett, WA

Podium 2-3 HOLMIUM LASER ENUCLEATION OF THE PROSTATE: MULTIMEDIA DESCRIPTION OF

TECHNIQUE- Abstract #811
Brian C. Fong, MD: Western Washington Medical Group, Department of Urology, Everett, WA

Podium 2-4 PERCUTANEOUS RENAL CRYOABLATION: EARLY RESULTS FROM A PROSPECTIVE

DATABASE- Abstract # 825
CB Metcalfe MD, University of British Columbia Department of Urological Sciences. BJ Donnelly MD, University
of Calgary Division of Urology. M Welsh MD, University of Calgary Department of Radiology

Podium 2-5 WHAT IS THE APPROPRIATE LENGTH OF URETERAL ACCESS SHEATH

FOR FLEXIBLE URETEROSCOPY?- Abstract #836
Laura Chang Kit MD, Joel Teichman MD: University of British Columbia; Department of Urology, St Paul’s
Hospital, Vancouver, BC Canada

Podium 2-6 REDUCTION OF STONE FRAGMENT RETROPULSION WITH ANTIRETROPULSION DEVICES

Abstract #823
B. H. Chew MD, L.M. Jonat MD, R. F. Paterson, J. MD, M.H. Teichman MD: University of British Columbia,
Vancouver, BC, Canada
Podium 2-7 URETEROSCOPIC LASER ENDOPAPILLOTOMY TO TREAT CHRONIC FLANK PAIN
ASSOCIATED WITH PAPILLARY CALCIFICATIONS – Abstract #813
Yehoshua Gdor MD, Stephen Faddegon MD, Ahmed H. Gabr MD, William W. Roberts MD,
Gary J. Faerber MD, Joel M.H. Teichman MD, J. Stuart Wolf M, Jr. MD
Department of Urology, University of Michigan, Ann Arbor, MI, USA;
Dept. of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada

Podium 2-8 INTRARENAL ULTRASOUND (IRUS) - A NOVEL TECHNOLOGY TO SIZE KIDNEY STONES
DURING URETEROSCOPY- Abstract #802
Mathew D. Sorensen, MD, MS, Michael R. Bailey, PhD: Department of Urology, University of Washington School
of Medicine, Seattle, WA

4:15 Point-Counter Point- Management of

High Grade T1 Bladder Cancer
Donald Lamm, M.D.- BCG

Sia Daneshmand, M.D.- Radical Cystectomy

Cases/Discussion

5:00 Adjourn
 Saturday Dec 6, 2008

9:00 Scientific Session III:

Female Urology/Voiding Dysfunction

Podium 3-1 TRANSURETHRAL RADIOFREQUENCY COLLAGEN DENATURATION- Abstract #821

Denise Elser, MD
GK Mitchell, MD; JR Miklos, MD; KG Nickell, MD; K Cline, MD: H Winkler, MD; WG Wells, MD

Podium 3-2 DEFINING SUCCESS FOLLOWING SLING SURGERY: ASSOCIATION OF SATISFACTION

WITH PATIENT REPORTED OUTCOMES- Abstract #818
David E Rapp MD, Nancy J Neil MD, Alvaro Lucioni MD, Kathleen C Kobashi MD
The Continence Center at Virginia Mason Medical Center, Seattle, WA
Lifecycle Sciences Group, Icon Clinical Research, San Francisco, CA

Podium 3-3 PRE-OPERATIVE URODYNAMIC PARAMETERS DO NOT CORRELATE WITH RESPONSE TO

BTX INJECTION IN PATIENTS WITH DETRUSOR OVERACTIVITY- Abstract #816
David E Rapp MD, Alvaro Lucioni MD, Jason Kim MD, W Stuart Reynolds MD, Kathleen C Kobashi MD,
Gregory T Bales MD
The Continence Center at Virginia Mason Medical Center, Seattle, WA
The University of Chicago Hospitals, Chicago, IL

Podium 3-4 OUTCOMES FOLLOWING MID-URETHRAL SLING PLACEMENT IN PATIENTS WITH

INTRINSIC SPHINCTERIC DEFICIENCY: COMPARISON OF SPARC AND MONARC SLINGS
Abstract #817
David E Rapp MD, Alvaro Lucioni MD, Fred E Govier MD, Kathleen C Kobashi MD
The Continence Center at Virginia Mason Medical Center, Seattle, WA

Podium 3-5 TEST-RETEST RELIABILITY OF REPEATED PRESSURE FLOW URODYNAMIC STUDIES

DURING A SINGLE SESSION IN WOMEN- Abstract #815
Justin Lee , Abhishek Seth MD, Ramon Geurro MD, Lynn Stothers MD: Department of Urological Science,
University of British Columbia, Vancouver, BC

9:45 Scientific Session IV:

Pediatrics

Podium 4-1 THE USE OF PATIENT-ACQUIRED DIGITAL IMAGES FOR POSTOPERATIVE CARE
Abstract #828
Van Ginger MD, Thomas Lendvay MD, Byron Joyner MD, Martin Koyle MD: Children’s Hospital & Regional
Medical Center, Seattle, WA

Podium 4-2 PROGNOSTIC FACTORS IN RESOLUTION OF ANTENATALLY DIAGNOSED

HYDRONEPHROSIS: A MULTIVARIABLE ANALYSIS- Abstract #824
M. Longpre MD, D. Yanko MD, S. Jafari MD, K. Afshar MD
University of British Columbia

Podium 4-3 TECHNIQUE OF UMBILICAL RECONSTRUCTION USING A TWO-FACED FLAP TECHNIQUE

Abstract #807
Stephanya Shear, MD MPH , Byron Joyner, M.D., Margarett Shnorhavorian, M.D., M.P.H., Thomas Lendvay,
M.D., Martin Koyle, M.D.Richard. W. Grady, M.D.: Children’s Hospital & Regional Medical Center, Seattle, WA
Podium 4-4 URODYNAMIC PROFILE FINDINGS FOLLOWING BLADDER AUTOAUGMENTATION
Abstract #808
Jennifer Foti MD, Ismael Zamilpa MD, Thomas Lendvay MD, Richard Grady MD
Children's Hospital and Regional Medical Center; Seattle, Washington

10:15 Scientific Session V:

Transplant/Infertiltiy

Podium 5-1 GRAFT AND CORRUPTION - THE USE OF ARTIFICIAL VASCULAR GRAFTS
IN KIDNEY TRANSPLANTATION- Abstract #830
Christian S. Kuhr MD and Thomas R. Hefty MD: Virginia Mason Medical Center, Seattle, WA

Podium 5-2 PREDICTION OF DELAYED GRAFT FUNCTION (DGF) AFTER DECESASED-DONOR RENAL
TRANSPLANTATION- Abstract #820
Jason C. Hedges, M.D., Ph.D., J. C. Prather, Ph.D., John M. Barry, M.D.
Division of Urology & Renal Transplantation, Oregon Health & Science University

Podium 5-3 DURING VASECTOMY REVERSAL SURGERY, THE PROBABILITY OF EPIDIDYMAL BYPASS
RATHER THAN VASOVASOSTOMY INCREASES AS TIME FROM VASECTOMY LENGTHENS- Abstract
#805
Gregory S. Taylor M.D., Molly E. Fuchs, B.A., Lisa B. Bland, M.D., M.P.H., Eugene F. Fuchs M.D.: Oregon Health
& Science University

Podium 5-4 DURING VASECTOMY REVERSAL, FINDING ONLY SPERM HEADS IN PROXIMAL VAS
FLUID PREDICTS TECHNICAL SUCCESS- Abstract #806
Lisa B. Bland, M.D., M.P.H., Molly E. Fuchs, B.A.*, Eugene F. Fuchs, M.D.: Oregon Health & Science University

10:45 Break/ Exhibit Hall

11:15 State of the Art Lecture:

Robotic Renal Surgery
Sam Bhayani, M.D., Co-Director of Robotic Surgery, Assistant Professor of Urology and Surgery, Washington
University School of Medicine, St. Louis, MO

12:00 Lunch

1:00 Scientific Session VI:

Oncology II

Podium 6-1 TIME TO TREATMENT OF PROSTATE CANCER THROUGH THE CALGARY PROSTATE
INSTITUTE RAPID ACCESS CLINIC- Abstract #822
A.G Kavanagh MD, J.C. Lee MD, B. Donnelly MD, University of Calgary

Podium 6-2 ARE ROUTINE METASTATIC SURVEYS WARRANTED FOR INTERMEDIATE RISK PROSTATE
CANCER? Abstract #819
Andrew Locke, Erin Odom and John M. Corman, M.D.: Virginia Mason Medical Center, Seattle, WA

Podium 6-3 TRANSURETHRAL PROSTATE BIOPSY FOR CANCER DETECTION

IN PATIENTS UNDERGOING SERIAL BIOPSIES- Abstract #833
Gregory T. Adams MD, Gregory S. Rosenblatt MD, Shane Rogosin MD, Solange Mongoue-Tchokote MS, Mark
Garzotto, MD; Oregon Health & Science University, Portland, OR.

Podium 6-4 DIFFERENTIAL TARGET IDENTIFICATION OF STATIN THERAPY IN ANDROGEN –

SENSITIVE AND –INSENSITIVE PROSTATE CANCER CELLS- Abstract #834
Mark Garzotto MD, Nicole M. Janeba B.A and Jackilen Shannon PhD.
Oregon Health & Science University, Portland, OR.

Podium 6-5 EFFECT OF OBESITY ON PSA DENSITY: IMPLICATIONS FOR IMPROVED DETECTION OF
PROSTATE CANCER- Abstract #832
Maire Brennan MS, Solange Mongoue-Tchokote PhD, Jackilen Shannon PhD, Motomi Mori, and Mark Garzotto
MD. Oregon Health & Science University, Portland OR.

Podium 6-6 PHASE I TRIAL OF IPILIMUMAB (IPI) ALONE AND IN COMBINATION WITH
RADIOTHERAPY (XRT) IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE
CANCER (MCRPC)- Abstract #829
TM Beer,1 SF Slovin,2 CS Higano,3 S Tejwani,4 TB Dorff,5 HI Scher,2 I Lowy,6 and the Prostate Cancer Clinical
Trials Consortium. 1Oregon Health & Science University, 2Memorial Sloan Kettering Cancer Center, 3University of
Washington, 4Henry Ford Health System, 5The Angeles Clinic and Research Institute, 6Medarex, Inc.

Podium 6-7 DAVINCI PROSTATECTOMY: RESULTS FROM 500 CONSECUTIVE PATIENTS- Abstract # 840
James Porter MD and Uzay Yasar MD, Swedish Urology Group, Seattle, WA

Podium 6-8 ROBOTIC PARTIAL NEPHRECTOMY- Abstract # 839

James Porter, MD ,Swedish Urology Group, Seattle, WA

1:55 Guest Lecture:

CT Urography -- Imaging the patient with painless hematuria
Larry Chow, M.D., Associate Professor of Radiology, Oregon Health & Science University

2:30 Break/Exhibit Hall

3:00 Scientific Session VII:

Miscellaneous

Podium 7-1 THE ADULT TEMPLATE CIRCUMCISION: A NOVEL TECHNIQUE- Abstract #803
Jennifer L. Gurski MD, Brian J. DeCastro MD, Andrew C. Peterson MD
Madigan Army Medical Center, Tacoma, WA.

Podium 7-2 USE OF AN OMENTAL WRAP IN URETEROLYSIS- Abstract #801

Jason P. Smith, M.D., Eric Reid, M.D., Aaron Bayne, M.D., Stephen Dunn, M.D., Thomas Hatch, M.D.
Oregon Health and Sciences University
Portland VA Medical Center

Podium 7-3 APPENDICEAL SUBSTITUTION FOLLOWING RIGHT PROXIMAL URETER INJURY

Abstract #827
Matt Ashley B.A., Sia Daneshmand, MD: Oregon Health & Science University, Portland, OR

Podium 7-4 EVALUATION AND TREATMENT OF LOIN PAIN HEMATURIA SYNDROME- Abstract #812
Eric S. Reid, MD and John M. Barry, MD: Division of Urology and Renal Transplantation, Portland, OR

Podium 7-5 HUGH HAMPTON YOUNG: FOREFATHER OF AMERICAN UROLOGIC SURGERY

Abstract #814
Brian Duty, M.D. Division of Urology & Renal Transplantation, Oregon Health & Science University
3:30 Management of Clinical Stage I Testis Cancer in 2008
-Craig Nichols, M.D., Director, Providence Cancer Center

4:00 Keynote Speaker:

Management of Patients with BCG Failure Donald Lamm, M.D.
Vice Chair for Research – Urologic Oncology
Department of Urology, Mayo Clinic
Scottsdale, Arizona

4:30 Interactive Case Discussions

5:00 Adjourn